Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell therapies for serious medical conditions, today reported its third ...
In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...
People who've suffered spinal cord injuries are more likely to develop an array of chronic health problems, Mass General ...
Get the latest on Lineage Cell Therapeutics' Q3 2025 earnings: clinical advances in OpRegen, new partnerships, and extended cash runway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback